Parallel Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Parallel Advisors’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18	Closed	-$585	–	3508
2023 Q2	$585	Buy	18 +1	+6%	+$37	﹤0.01%	3066
2023 Q1	$665	Buy	17 +6	+55%	+$293	﹤0.01%	3049
2022 Q4	$581	Hold	11	–	–	﹤0.01%	3007
2022 Q3	$0	Sell	11 -110	-91%	-$4.73K	﹤0.01%	3573
2022 Q2	$4K	Hold	121	–	–	﹤0.01%	2397
2022 Q1	$5K	Buy	121 +11	+10%	+$387	﹤0.01%	2331
2021 Q4	$5K	Hold	110	–	–	﹤0.01%	2436
2021 Q3	$6K	Hold	110	–	–	﹤0.01%	2316
2021 Q2	$5K	Hold	110	–	–	﹤0.01%	2322
2021 Q1	$6K	Hold	110	–	–	﹤0.01%	2152
2020 Q4	$7K	Hold	110	–	–	﹤0.01%	1946
2020 Q3	$7K	Hold	110	–	–	﹤0.01%	1924
2020 Q2	$4K	Hold	110	–	–	﹤0.01%	2047
2020 Q1	$3K	Hold	110	–	–	﹤0.01%	2072
2019 Q4	$4K	Hold	110	–	–	﹤0.01%	2069
2019 Q3	$4K	Buy	+110	New	+$4.38K	﹤0.01%	2022

Other funds holding SILK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Parallel Advisors's SILK Position: Q3 2023 in Review

Parallel Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2023, closing a stake of 18 shares — an estimated $585 sold.

Parallel Advisors first reported a position in SILK in Q3 2019 and held it in 16 quarters. The position peaked at $7K in Q4 2020. 166 funds tracked by Wall St. Rank hold SILK as of Q3 2023.

Parallel Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Parallel Advisors sold 18 Silk Road Medical, Inc. Common Stock shares in Q3 2023, an estimated $585.
Parallel Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2019 and held it in 16 quarters.
Parallel Advisors's Silk Road Medical, Inc. Common Stock position peaked at $7K in Q4 2020.
166 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2023.

Based on Parallel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.